HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew C Cheung Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

11/2021Statins in mature B-cell lymphomas and leukaemias.
1/2019Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent.
6/2014Survival of patients with transformed lymphoma in the rituximab era.
4/2007Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew C Cheung Research Topics

Disease

21Neoplasms (Cancer)
04/2024 - 06/2005
12Lymphoma (Lymphomas)
01/2023 - 06/2006
10Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 04/2007
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2023 - 04/2007
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2022 - 02/2015
4B-Cell Lymphoma (Lymphoma, B Cell)
11/2021 - 04/2007
4Hodgkin Disease (Hodgkin's Disease)
02/2020 - 04/2010
3COVID-19
10/2023 - 01/2022
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 04/2016
3Multiple Myeloma
09/2021 - 03/2016
3Acquired Immunodeficiency Syndrome (AIDS)
04/2010 - 06/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 01/2021
2Infections
01/2023 - 01/2022
2Breast Neoplasms (Breast Cancer)
01/2022 - 07/2021
2Thrombocytopenia (Thrombopenia)
10/2021 - 04/2018
2Anemia
10/2021 - 03/2016
2Death (Near-Death Experience)
01/2020 - 09/2015
2Neutropenia
04/2018 - 01/2014
2Disease Progression
03/2016 - 11/2014
2Febrile Neutropenia
01/2014 - 12/2010
1Heart Failure
04/2024
1Frailty
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Chronic Obstructive Pulmonary Disease (COPD)
10/2021
1Thrombotic Microangiopathies
09/2021
1Leukemia
12/2020
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
10/2020
1Pure Red-Cell Aplasia
10/2020
1Overweight
01/2019
1Rubella (German Measles)
04/2018
1Exanthema (Rash)
03/2016
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
11/2014
1Rare Diseases (Rare Disease)
11/2014
1Obesity
12/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2007

Drug/Important Bio-Agent (IBA)

13Rituximab (Mabthera)FDA Link
10/2023 - 04/2007
7Prednisone (Sone)FDA LinkGeneric
01/2023 - 10/2012
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 10/2012
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 10/2012
6Vincristine (Oncovin)FDA LinkGeneric
01/2023 - 10/2012
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2023 - 07/2015
4Azacitidine (5 Azacytidine)FDA Link
11/2023 - 02/2015
3Guanosine Diphosphate (GDP)IBA
01/2023 - 07/2015
3GemcitabineFDA Link
01/2023 - 07/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 07/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2022 - 11/2020
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2019
2Bendamustine HydrochlorideFDA Link
01/2023 - 11/2021
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023 - 07/2015
2ibrutinibIBA
11/2021 - 01/2019
2ibritumomab tiuxetan (Zevalin)FDA Link
04/2018 - 06/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2014 - 12/2010
2Methotrexate (Mexate)FDA LinkGeneric
09/2012 - 10/2011
1venetoclaxIBA
11/2023
1VaccinesIBA
01/2023
1Heme (Haem)IBA
01/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2022
1COVID-19 VaccinesIBA
01/2022
1polatuzumab vedotinIBA
01/2022
1ORALIT (ORS)IBA
01/2022
1CreatinineIBA
10/2021
1carfilzomibIBA
09/2021
1AlbuminsIBA
12/2020
1Metformin (Glucophage)FDA LinkGeneric
11/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2020
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2020
1romidepsin (FK228)FDA Link
01/2019
1InterferonsIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
04/2018
1Lenalidomide (CC 5013)FDA Link
03/2016
1Melphalan (Alkeran)FDA LinkGeneric
03/2016
1Thalidomide (Thalomid)FDA Link
03/2016
1eculizumabFDA Link
11/2014
1R-CHOP protocolIBA
06/2014
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2014
1Dacarbazine (DIC)FDA LinkGeneric
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1Protease Inhibitors (Protease Inhibitor)IBA
04/2010
1pipoxolan (BR 18)IBA
12/2009

Therapy/Procedure

14Therapeutics
01/2023 - 06/2005
13Drug Therapy (Chemotherapy)
01/2022 - 06/2005
4Immunotherapy
11/2020 - 04/2018
4Radiotherapy
01/2020 - 10/2011
3Highly Active Antiretroviral Therapy (HAART)
04/2010 - 06/2005
2Ambulatory Care (Outpatient Care)
01/2023 - 01/2021
2Transplantation
02/2020 - 10/2019
2Terminal Care (Care, Terminal)
01/2020 - 09/2015
2Palliative Care (Palliative Therapy)
01/2020 - 09/2015
1Immunomodulation
04/2024
1Induction Chemotherapy
11/2023
1Operative Surgical Procedures
01/2022
1Neoadjuvant Therapy
01/2022
1Plasma Exchange
09/2021
1Precision Medicine
01/2021
1Drug Tapering
01/2019
1Stem Cell Transplantation
07/2015
1Treatment Delay
02/2015
1Combined Modality Therapy
09/2012